Baupost Group Discloses 35 Percent Stake In Idenix PharmaceuticalsVW Staff
Baupost Group, the hedge fund founded and managed by Seth Klarman, disclosed ownership of 53,331,109 shares (a 35.38% stake) in Idenix Pharmaceuticals Inc (NASDAQ:IDIX) based on its 13D filing with the Securities and Exchange Commission (SEC), and as first reported by . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.